Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Foo, K.
Right arrow Articles by Timmis, A. D
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: Managing the diabetic patient with angina

Kong Foo

Department of Cardiology, Newham General Hospital, London, E13 8RU, UK

Adam D Timmis

Department of Cardiology, London Chest Hospital, London, E2 9JX, UK, timmis{at}lch.demon.co.uk

Angina is common in the adult diabetic population. The symptoms of diabetic angina are commonly atypical, and often absent (silent ischaemia). Conventional anti-anginal drugs are effective in diabetic patients, but referral for angiography and consideration of percutaneous or surgical revascularisation is necessary if symptoms persist. Secondary prevention strategies are reviewed within the context of medical and surgical treatment options.

Key Words: diabetes • angina • coronary angioplasty • revascularisation.

References

  • Di Carli MF, Bianco-Batlles D., Landa ME et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999;100:813-9.[Abstract/Free Full Text]
  • Storstein L., Jervell J. Response to bicycle exercise testing in long-standing juvenile diabetes. Acta Med Scand 1979;205:227-30.[Web of Science][Medline] [Order article via Infotrieve]
  • Hilsted J., Galbo H., Christensen NJ Impaired cardiovascular responses to graded exercise in diabetic autonomic neuropathy. Diabetes 1979;28: 313-9.[Web of Science][Medline] [Order article via Infotrieve]
  • Hypertension in Diabetes Study Group, HDS. 1: Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993;11:309-17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • United Kingdom Prospective Diabetes Study (UKPDS) Group. Risk factors for coronary artery disease in non-insulin dependent diabetes (UKPDS 23). BMJ 1998;316:823-8.[Abstract/Free Full Text]
  • Giri S., Shaw LJ, Murthy DR et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.[Abstract/Free Full Text]
  • Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Uusitupa MIJ. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM: ten-year follow-up from the diagnosis. Diabetes 1996; 45:308-15.[Abstract]
  • Ambepityia G., Kopelman PG, Ingram D., Swash M., Mills PG, Timmis AD Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol 1990;15:72-7.[Abstract]
  • Marchant B., Umachandran V., Stevenson R., Kopelman PG, Timmis AD Silent myocardial ischaemia: the role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993;22:1433-7.[Abstract]
  • Nesto RW Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care 1999;22:1393-5.[Free Full Text]
  • Sayer JW, Timmis AD Investigation of coronary artery disease in diabetes; is screening of asymptomatic patients necessary? Heart 1997;78: 525-6.[Free Full Text]
  • Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognised silent myocardial ischemia and its association with atherosclerotic risk factors in non insulin-dependent diabetes mellitus. Am J Cardiol 1997;79:134-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Koistinen MJ Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 1990;301:92-5.[Abstract/Free Full Text]
  • Manske CL, Wilson RF, Wang Y., Thomas W. Atherosclerotic vascular complications in diabetic transplant candidates. Am J Kidney Dis 1997; 29:601-7.[Web of Science][Medline] [Order article via Infotrieve]
  • Nesto RW, Watson FS, Kowalchuk GJ et al. Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy. Am Heart J 1990;120:1073-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Younis LT, Miller DD, Chaitman BR Preoperative strategies to assess cardiac risk before noncardiac surgery. Clin Cardiol 1995;18:447-54.[Web of Science][Medline] [Order article via Infotrieve]
  • Haffner SM, Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.[Abstract/Free Full Text]
  • Stamler J., Vaccaro O., Neaton J. et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.[Abstract]
  • United Kingdom Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998;317:703-13.[Abstract/Free Full Text]
  • Hansson L., Zanchetti A., Carruthers SG et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension optimal treatment (HOT) randomised trial. Lancet 1998;352:1252-68.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Collins R., Peto R., MacMahon S. et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • United Kingdom Prospective Diabetes Study (UKPDS) Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.[Abstract/Free Full Text]
  • Malmberg K., Ryden L., Efendic S. et al. for the Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study Group. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction: effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.[Abstract]
  • UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fuchtenbusch M., Standl E., Schatz H. Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2000;108:151-63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pyorala K., Pederson T., Kjekshus J. et al., and the Scandinavian Simvastatin Survival Study (4S) Group. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20:614-20.[Abstract]
  • Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.[Abstract/Free Full Text]
  • Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.[Abstract/Free Full Text]
  • Wood D., Durrington P., Poulter N., McInnes G., Rees A., Wray R. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80(suppl 2):1-26.[Free Full Text]
  • Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 1998; 97:946-52.[Abstract/Free Full Text]
  • Sacks FM, Tonkin AM, Craven T. et al. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors. Circulation 2002;105:1424-8.[Abstract/Free Full Text]
  • Rubins HB, Robins SJ, Collins D. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410-8.[Abstract/Free Full Text]
  • Davi G., Ciabottoni G., Consoli A. et al. In vivo formation of 8-iso-prostaglandin F2a and platelet activation in diabetes mellitus: effects of improved metabolic control. Circulation 1999;99:224-9.[Abstract/Free Full Text]
  • Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of randomised trials of antiplatelet therapy - 1: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.[Abstract/Free Full Text]
  • The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.[Abstract/Free Full Text]
  • Malmberg K., Herlitz J., Hjalmarson A., Ryden L. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction: retrospective data from two large studies. Eur Heart J 1989; 10:423-8.[Abstract/Free Full Text]
  • Timmis AD, Sayer J. ACE Inhibition and Coronary Artery Disease. London: Science Press 1997.
  • Mancini GB, Henry GC, Macaya C. et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996;94:258-65.[Abstract/Free Full Text]
  • Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: result of HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lindholm LH, Ibsen H., Dahlof B. et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:1004-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.[Abstract/Free Full Text]
  • Niles NW, McGrath PD, Malenka D. et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 2001;37:1008-15.[Abstract/Free Full Text]
  • Marso SP, Lincoff AM, Ellis SG et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation 1999;100:2477-84.[Abstract/Free Full Text]
  • Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 2000;35:922-8.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 3, 169-175 (2002)
DOI: 10.1177/14746514020020030401
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Foo, K.
Right arrow Articles by Timmis, A. D
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?